being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug is approved for use in "people at least 12 years old and weighing at least 88 pounds (40 kilograms) who are hospitalized for a coronaviru